These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16378695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS, Attenburrow MJ, Cowen PJ.
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [Abstract] [Full Text] [Related]

  • 3. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
    Lotrich FE, Bies R, Muldoon MF, Manuck SB, Smith GS, Pollock BG.
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-dose citalopram as a 5-HT neuroendocrine probe.
    Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ.
    Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
    [Abstract] [Full Text] [Related]

  • 6. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
    Henning J, Netter P.
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
    [Abstract] [Full Text] [Related]

  • 7. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
    Seifritz E, Müller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U, Moore P, Holsboer-Trachsler E.
    J Psychiatr Res; 1997 Mar; 31(5):543-54. PubMed ID: 9368196
    [Abstract] [Full Text] [Related]

  • 8. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER, Owen JA, Hudson RW, Delva NJ.
    Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
    [Abstract] [Full Text] [Related]

  • 9. Acute hormonal changes after IV citalopram and treatment response in OCD.
    Corregiari FM, Gattaz WF, Bernik M.
    Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272
    [Abstract] [Full Text] [Related]

  • 10. Acute citalopram administration produces correlated increases in plasma and salivary cortisol.
    Bhagwagar Z, Hafizi S, Cowen PJ.
    Psychopharmacology (Berl); 2002 Aug; 163(1):118-20. PubMed ID: 12185409
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of serotoninergic challenge with oral citalopram.
    Mattos P, Franco VA, Noel F, Segenreich D, Gonçalves JC.
    Braz J Psychiatry; 2006 Sep; 28(3):203-5. PubMed ID: 17063220
    [Abstract] [Full Text] [Related]

  • 12. Citalopram challenge in social anxiety disorder.
    Shlik J, Maron E, Tru I, Aluoja A, Vasar V.
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
    Allott K, Canny BK, Broadbear JH, Stepto NK, Murphy B, Redman J.
    J Psychopharmacol; 2009 Sep; 23(7):759-74. PubMed ID: 18562414
    [Abstract] [Full Text] [Related]

  • 14. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD, Manuck SB, Perel JM, Muldoon MF.
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine effects of citalopram infusion in anorexia nervosa.
    Mondelli V, Gianotti L, Picu A, Abbate Daga G, Giordano R, Berardelli R, Pariante CM, Fassino S, Ghigo E, Arvat E.
    Psychoneuroendocrinology; 2006 Nov; 31(10):1139-48. PubMed ID: 17045409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.
    Brunswick DJ, Goodman DB, O'Reardon JP, Chopra M, Amsterdam JD.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):477-80. PubMed ID: 15093954
    [Abstract] [Full Text] [Related]

  • 18. State and trait abnormalities in serotonin function in major depression.
    Bhagwagar Z, Whale R, Cowen PJ.
    Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
    Berardelli R, Margarito E, Ghiggia F, Picu A, Balbo M, Bonelli L, Giordano R, Karamouzis I, Bo M, Ghigo E, Arvat E.
    J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.